Tonje Amb Aksnes

  • MD; PhD
  • +4702900
Department of Cardiology, Akershus University Hospital, Oslo, Norway
 

Original articles

Knudsen EC, Seljeflot I, Aksnes TA, Eritsland J, Arnesen H, Andersen GØ (2019)
IgM antibodies against phosphorylcholine measured early after acute ST-elevation myocardial infarction in relation to atherosclerotic disease burden and long-term clinical outcome
PLoS One, 14 (4), e0215640
DOI 10.1371/journal.pone.0215640, PubMed 31002684

Åkra S, Aksnes TA, Flaa A, Eggesbø HB, Opstad TB, Njerve IU, Seljeflot I (2018)
Interleukin-18 and the NLR family pyrin domain containing-3 inflammasome in adipose tissue are strongly associated with glucometabolic variables in a cohort of middle-aged men
Diab Vasc Dis Res, 15 (5), 458-464
DOI 10.1177/1479164118785307, PubMed 29972041

Aksnes TA, Kjeldsen SE, Rostrup M, Holzhauer B, Hua TA, Julius S (2016)
Predictors of cardiac morbidity in diabetic, new-onset diabetic and non-diabetic high-risk hypertensive patients: The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial
Blood Press, 25 (4), 235-40
DOI 10.3109/08037051.2015.1134071, PubMed 26808585

Skårn SN, Eggesbø HB, Flaa A, Kjeldsen SE, Rostrup M, Brunborg C, Reims HM, Aksnes TA (2015)
Predictors of abdominal adipose tissue compartments: 18-year follow-up of young men with and without family history of diabetes
Eur J Intern Med, 29, 26-31
DOI 10.1016/j.ejim.2015.11.027, PubMed 26712453

Skårn SN, Flaa A, Kjeldsen SE, Rostrup M, Brunborg C, Reims HM, Fossum E, Høieggen A, Aksnes TA (2015)
Family history of hypertension and serum triglycerides predict future insulin sensitivity: a 17-year follow-up study of young men
J Hypertens, 33 (9), 1845-51; discussion 1852
DOI 10.1097/HJH.0000000000000632, PubMed 26103130

Skårn SN, Flaa A, Kjeldsen SE, Rostrup M, Brunborg C, Reims HM, Fossum E, Høieggen A, Aksnes TA (2015)
High screening blood pressure at young age predicts future masked hypertension: A 17 year follow-up study
Blood Press, 24 (3), 131-8
DOI 10.3109/21695717.2015.1030889, PubMed 25901999

Schultz M, Aksnes TA, Høieggen A, Kjeldsen SE (2013)
[Choice of drug in hypertension]
Tidsskr Nor Laegeforen, 133 (17), 1802-3
DOI 10.4045/tidsskr.13.0311, PubMed 24042290

Aksnes TA, Kjeldsen SE (2010)
A link between hypertension and atrial fibrillation: methods of treatment and prevention
Curr Vasc Pharmacol, 8 (6), 769-74
DOI 10.2174/157016110793563807, PubMed 20626338

Flaa A, Aksnes TA, Kjeldsen SE, Eide I, Rostrup M (2008)
Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study
Metabolism, 57 (10), 1422-7
DOI 10.1016/j.metabol.2008.05.012, PubMed 18803948

Aksnes TA, Flaa A, Strand A, Kjeldsen SE (2008)
Prevention of atrial fibrillation in hypertension
Curr Hypertens Rep, 10 (3), 175-81
DOI 10.1007/s11906-008-0034-x, PubMed 18765086

Aksnes TA, Kjeldsen SE, Rostrup M, Störset O, Hua TA, Julius S (2008)
Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial
J Hum Hypertens, 22 (8), 520-7
DOI 10.1038/jhh.2008.41, PubMed 18509347

Aksnes TA, Schmieder RE, Kjeldsen SE, Ghani S, Hua TA, Julius S (2008)
Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial)
Am J Cardiol, 101 (5), 634-8
DOI 10.1016/j.amjcard.2007.10.025, PubMed 18308012

Aksnes TA, Flaa A, Sevre K, Mundal HH, Rostrup M, Kjeldsen SE (2008)
Effects on plasma noradrenaline may explain some of the improved insulin sensitivity seen by AT-1 receptor blockade
Blood Press, 17 (3), 156-63
DOI 10.1080/08037050802162847, PubMed 18608197

Aksnes TA, Seljeflot I, Torjesen PA, Höieggen A, Moan A, Kjeldsen SE (2007)
Improved insulin sensitivity by the angiotensin II-receptor blocker losartan is not explained by adipokines, inflammatory markers, or whole blood viscosity
Metabolism, 56 (11), 1470-7
DOI 10.1016/j.metabol.2007.06.012, PubMed 17950096

Aksnes TA, Kjeldsen SE, Rostrup M, Omvik P, Hua TA, Julius S (2007)
Impact of new-onset diabetes mellitus on cardiac outcomes in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial population
Hypertension, 50 (3), 467-73
DOI 10.1161/HYPERTENSIONAHA.106.085654, PubMed 17679652

Aksnes TA, Reims HM, Guptha S, Moan A, Os I, Kjeldsen SE (2006)
Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors
J Hum Hypertens, 20 (11), 860-6
DOI 10.1038/sj.jhh.1002087, PubMed 16988754

Aksnes TA, Jacobsen D (2004)
[Smuggling of illegal drugs by body suffers]
Tidsskr Nor Laegeforen, 124 (13-14), 1772-3
PubMed 15229664

Aksnes TA, Nodenes K, Gjesdal K (2000)
[Use of tilt test in the investigation of syncope]
Tidsskr Nor Laegeforen, 120 (7), 803-6
PubMed 10806903

Review articles

Kjeldsen SE, Aksnes TA, Ruilope LM (2014)
Clinical implications of the 2013 ESH/ESC hypertension guidelines: targets, choice of therapy, and blood pressure monitoring
Drugs R D, 14 (2), 31-43
DOI 10.1007/s40268-014-0049-5, PubMed 24842751

Aksnes TA, Skårn SN, Kjeldsen SE (2012)
Treatment of hypertension in diabetes: what is the best therapeutic option?
Expert Rev Cardiovasc Ther, 10 (6), 727-34
DOI 10.1586/erc.12.59, PubMed 22894629

Aksnes TA, Kjeldsen SE, Schmieder RE (2009)
Hypertension and atrial fi brillation with emphasis on prevention
Blood Press, 18 (3), 94-8
DOI 10.1080/08037050903040744, PubMed 20499443

Flaa A, Aksnes TA, Strand A, Kjeldsen SE (2007)
Complications of hypertension and the role of angiotensin receptor blockers in hypertension trials
Expert Rev Cardiovasc Ther, 5 (3), 451-61
DOI 10.1586/14779072.5.3.451, PubMed 17489670

Aksnes TA, Flaa A, Strand A, Kjeldsen SE (2007)
Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure
J Hypertens, 25 (1), 15-23
DOI 10.1097/01.hjh.0000254378.26607.1f, PubMed 17143167

Aksnes TA, Kjeldsen SE, Mancia G (2006)
The effect of antihypertensive agents on new-onset diabetes mellitus: time to amend the guidelines?
Am J Cardiovasc Drugs, 6 (3), 139-47
DOI 10.2165/00129784-200606030-00001, PubMed 16780387

Aksnes TA, Reims HM, Kjeldsen SE, Mancia G (2005)
Antihypertensive treatment and new-onset diabetes mellitus
Curr Hypertens Rep, 7 (4), 298-303
DOI 10.1007/s11906-005-0029-9, PubMed 16061050

Other articles

Kjeldsen SE, Aksnes TA, Mo R, Klemsdal TO (2019)
Impact of the New ACC/AHA and ESC/ESH Hypertension Guidelines for Norway
Eur Heart J, 40 (19), 1485-1487
DOI 10.1093/eurheartj/ehz266, PubMed 31087051

Kjeldsen SE, Aksnes TA, Wachtell K, Okin PM (2016)
Arterial Stiffness Predicts Incident Atrial Fibrillation in the Framingham Heart Study: A Mechanistic Contribution in People With High Blood Pressure or History of Hypertension
Hypertension, 68 (3), 555-7
DOI 10.1161/HYPERTENSIONAHA.116.07671, PubMed 27456524

Gerdts E, Aksnes TA, Hultström M, Kjeldsen SE, Os I (2014)
Ingrid Toft (June 2, 1959-April 26, 2014)
Blood Press, 23 (4), 255
DOI 10.3109/08037051.2014.938919, PubMed 25014276

Kjeldsen SE, Schultz M, Vinkenes K, Aksnes TA, Høieggen A (2013)
[Blood Pressure Treatment--towards consensus on many things]
Tidsskr Nor Laegeforen, 133 (21), 2226
DOI 10.4045/tidsskr.13.1374, PubMed 24226313

Hultstrom M, Aksnes TA, Gerdts E, Kjeldsen SE, Toft I (2011)
Bjarne Magnus Iversen (30 March 1942-5 August 2011) OBITUARY
Blood Pressure, 20 (5), 317

Theses

Aksnes TA (2008)
The risk of developing diabetes in hypertension: insulin sensitivity, AT-1 receptor blockade and sympathetic activity
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 704, 1 b. (flere pag.)
BIBSYS 082872341, ISBN 978-82-8072-912-5

Page visits: 4312